{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:33:48Z","timestamp":1761557628791,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.sapharm.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:30:30Z","timestamp":1655551830000},"page":"4012-4015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal A.","family":"Cadogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.sapharm.2022.05.012_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatr"},{"issue":"662","key":"10.1016\/j.sapharm.2022.05.012_bib2","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.3399\/bjgp17X691865","article-title":"Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected]","volume":"67","author":"Davies","year":"2017","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2022.05.012_bib3","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005-2015","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.sapharm.2022.05.012_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits. A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.sapharm.2022.05.012_bib5","article-title":"Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: a rapid review","author":"Niznik","year":"2021","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2022.05.012_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.sapharm.2022.05.012_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2046-4053-1-10","article-title":"Evidence summaries: the evolution of a rapid review approach","volume":"1","author":"Khangura","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.sapharm.2022.05.012_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jclinepi.2020.09.041","article-title":"Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews","volume":"129","author":"Hamel","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2022.05.012_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jclinepi.2018.12.015","article-title":"Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study","volume":"109","author":"Marshall","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.sapharm.2022.05.012_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/jgs.15751","article-title":"Deprescribing in the pharmacologic management of delirium: a randomized trial in the intensive care unit","volume":"67","author":"Campbell","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2022.05.012_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/2042098618816562","article-title":"The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study","volume":"10","author":"Gnjidic","year":"2019","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"10.1016\/j.sapharm.2022.05.012_bib12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"18","key":"10.1016\/j.sapharm.2022.05.012_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.sapharm.2022.05.012_bib14","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/add.14981","article-title":"Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis","volume":"115","author":"Lynch","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.sapharm.2022.05.012_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/1606635310001634528","article-title":"Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention","volume":"12","author":"Heather","year":"2004","journal-title":"Addiction Res Theor"},{"key":"10.1016\/j.sapharm.2022.05.012_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-161","article-title":"Patient education and pharmacist consultation influence on nonbenzodiazepine sedative medication deprescribing success for older adults","volume":"23","author":"Kuntz","year":"2019","journal-title":"Perm J"},{"issue":"12","key":"10.1016\/j.sapharm.2022.05.012_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4140\/TCP.n.2018.711.","article-title":"Clinical pharmacist intervention to engage older adults in reducing use of alprazolam","volume":"33","author":"Navy","year":"2018","journal-title":"Consult Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2022.05.012_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/16066350801900297","article-title":"Randomised controlled trial of two brief interventions against long-term benzodiazepine use: cost-effectiveness","volume":"16","author":"Godfrey","year":"2008","journal-title":"Addiction Res Theor"},{"issue":"1","key":"10.1016\/j.sapharm.2022.05.012_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:29:20Z","timestamp":1761557360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741122001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1551741122001760"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.05.012","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}